company-logo

IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 and 1009 research programs for the treatment of neurodegenerative disorders and ageing; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is based in Gothenburg, Sweden.

IRLAB Therapeutics Dividend Announcement

IRLAB Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on IRLAB Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

IRLAB Therapeutics Dividend History

IRLAB Therapeutics Dividend Yield

IRLAB Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing IRLAB Therapeutics stock? Use our calculator to estimate your expected dividend yield:

IRLAB Therapeutics Financial Ratios

P/E ratio-6.03
PEG ratio0.12
P/B ratio17.87
ROE-150.18%
Payout ratio0.00%
Current ratio0.87
Quick ratio0.87
Cash Ratio0.77

IRLAB Therapeutics Dividend FAQ

Does IRLAB Therapeutics stock pay dividends?
IRLAB Therapeutics does not currently pay dividends to its shareholders.
Has IRLAB Therapeutics ever paid a dividend?
No, IRLAB Therapeutics has no a history of paying dividends to its shareholders. IRLAB Therapeutics is not known for its dividend payments.
Why doesn't IRLAB Therapeutics pay dividends?
There are several potential reasons why IRLAB Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will IRLAB Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While IRLAB Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is IRLAB Therapeutics a dividend aristocrat?
IRLAB Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is IRLAB Therapeutics a dividend king?
IRLAB Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is IRLAB Therapeutics a dividend stock?
No, IRLAB Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy IRLAB Therapeutics stocks?
To buy IRLAB Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy IRLAB Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.